Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China flag China · Delayed Price · Currency is CNY
16.17
-0.18 (-1.10%)
May 20, 2026, 11:34 AM CST

SHE:002603 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
783.991,105853.03940.511,904995.26
Trading Asset Securities
1,645764.42-205.97518.3855.27
Cash & Short-Term Investments
2,4291,869853.031,1462,4231,051
Cash Growth
108.31%119.14%-25.60%-52.68%130.61%-32.40%
Accounts Receivable
1,8651,6491,3902,5962,1782,361
Other Receivables
18.3616.09130.075.596.544.73
Receivables
1,8841,6651,5202,6022,1842,366
Inventory
1,3451,4891,7462,4592,0221,673
Prepaid Expenses
-4.6626.0993.90.739.39
Other Current Assets
128.23178.59189.28242.67624.8473.65
Total Current Assets
5,7865,2064,3356,5447,2545,602
Property, Plant & Equipment
6,8506,9477,2537,3116,2295,758
Long-Term Investments
2.465.576.51,6511,3491
Goodwill
101.72103.28109.51115.75--
Other Intangible Assets
784.51791.87802.57743.52724.01660.5
Long-Term Deferred Tax Assets
231.72218.35365.84183.58284.43117
Long-Term Deferred Charges
276.94260.12266.88189.37107.16239.33
Other Long-Term Assets
144.71142.72180.36241.39392.65527.03
Total Assets
14,17813,67513,31916,97916,34112,905
Accounts Payable
1,4991,4681,8972,8472,0611,621
Accrued Expenses
231.81336.31350.83419.64644.78269.71
Short-Term Debt
---600.35500.35702.48
Current Portion of Long-Term Debt
---201.12150.12-
Current Portion of Leases
11.749.698.245.55.8613.43
Current Income Taxes Payable
80.2836.8623.4642.45242.1511.38
Current Unearned Revenue
431.98305.76272.34287.521,106301.56
Other Current Liabilities
57.3751.3155.2643.58140.3540.7
Total Current Liabilities
2,3122,2082,6074,4474,8502,960
Long-Term Debt
---599.1200.15500.47
Long-Term Leases
11.716.0418.2113.0114.9712.53
Long-Term Unearned Revenue
355.42359.75377.92352.37335.02357.84
Long-Term Deferred Tax Liabilities
107.47109.11114.25130.1410.241.39
Total Liabilities
2,7872,6933,1175,5415,4113,833
Common Stock
1,6711,6711,6711,6711,6711,671
Additional Paid-In Capital
2,3242,3242,3432,3432,3432,343
Retained Earnings
7,4117,0026,2177,4436,9265,065
Comprehensive Income & Other
-7.45-7.83-7.12-6.61-7.22-9.71
Total Common Equity
11,39810,98910,22311,45010,9329,069
Minority Interest
-7.44-7.21-21.4-11.73-1.953.04
Shareholders' Equity
11,39110,98210,20211,43810,9309,072
Total Liabilities & Equity
14,17813,67513,31916,97916,34112,905
Total Debt
23.4425.7426.451,419871.451,229
Net Cash (Debt)
2,4061,844826.58-272.61,551-178.37
Net Cash Growth
111.16%123.04%----
Net Cash Per Share
1.441.100.49-0.160.93-0.11
Filing Date Shares Outstanding
1,6711,6711,6711,6711,6711,671
Total Common Shares Outstanding
1,6711,6711,6711,6711,6711,671
Working Capital
3,4732,9981,7282,0972,4042,642
Book Value Per Share
6.826.586.126.856.545.43
Tangible Book Value
10,51210,0949,31110,59010,2088,409
Tangible Book Value Per Share
6.296.045.576.346.115.03
Buildings
-5,9335,6685,4074,3533,620
Machinery
-3,8763,5813,0982,4842,005
Construction In Progress
-890.661,1971,4711,5741,950
Source: S&P Global Market Intelligence. Standard template. Financial Sources.